Hudson Bay Capital Management LP Bausch Health Companies Inc. Transaction History

Hudson Bay Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $1.53 Million - $2.6 Million	-250,000 Reduced 2.13%	11,500,000 $80.2 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $1.94 Million - $2.65 Million	250,000 Added 2.17%	11,750,000 $125 Million
Q1 2023 May 16, 2023	BUY	$6.28 - $9.85 $8.15 Million - $12.8 Million	1,298,240 Added 12.73%	11,500,000 $93.2 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $8.15 Million - $12.8 Million	-1,298,240 Reduced 11.29%	10,201,760 $82.6 Million
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $48.7 Million - $63.4 Million	8,000,000 Added 228.57%	11,500,000 $72.2 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $16 Million - $32.2 Million	3,500,000 New	3,500,000 $24.1 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.